Source:http://linkedlifedata.com/resource/pubmed/id/17924058
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2008-1-4
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0167-594X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
86
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
363-4
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:17924058-Antibodies, Monoclonal,
pubmed-meshheading:17924058-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:17924058-Female,
pubmed-meshheading:17924058-Humans,
pubmed-meshheading:17924058-Immunologic Factors,
pubmed-meshheading:17924058-Middle Aged,
pubmed-meshheading:17924058-Paraneoplastic Cerebellar Degeneration,
pubmed-meshheading:17924058-Treatment Outcome
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Successful treatment of paraneoplastic cerebellar degeneration with Rituximab.
|
| pubmed:publicationType |
Letter,
Case Reports
|